Americans are becoming more aware of GLP -1 drugs like Ozampics, WAGOVI: Survey
The number of US adults conscious of GLP -1 drugs used for weight loss such as Ojampic and Wagovi has jumped significantly in the past few years, a new survey showed.
The Yugov survey, published on Friday, found that at least 5 percent of respondents heard about semaglutide at least “a bit”, a drug used for the treatment of type 2 diabetes that help the user lose weight.
In March 2021, only 5 percent of the Americans were aware of the drug. A year later, in March 2024, this number stood at 70 percent, Polster mentioned. The latest survey also found that the share of those “lots” since 2021 has been almost doubled, which has risen from 23 percent to 41 percent.
Only 36 percent of the respondents say they know someone who has taken Semaglutide. According to the survey, about 5 percent of the family members took drugs, named 5 per cent as friends, 5 percent identified a acquaintance and the percent percentage said that they had taken it themselves, the survey said. Several have also mentioned that they knew one user in multiple sections.
According to the survey, women are higher than men, 43 percent to 29 percent, including themselves who have taken the GLP -1 Agronist drug.
Weight loss drugs, including Wagovi, Ojempic, Jepbound and others, have been found since 2005 but only in the last few years it was used to treat obesity. Drugs work by duping a hormone in the body-Glukagan-national peptide-1-which stimulates insulin emissions and reduces appetite.
Possible side effects of taking drugs include nausea, diarrhea, nausea and constipation.
Although semaglutd is currently determined for the treatment of weight loss or diabetes, the initial research is pointing to the potential advantage of addiction treatment, neurodizerrative disease and other problems, including the heart, kidney or liver.
The latest survey found that about a quarter respondents said they would be interested in taking “very” or “some” drugs as a weight loss treatment.
About a third of Americans are either taken into the drug or said they would be interested in trying it. On the other hand, about 1 percent percentage said that they were not very interested in the drug and gave 45 percent signals that they were not interested at all.
A separate survey last September found that about a quarter of adults in the United States would consider using weight loss drugs without consulting their doctor.
The UGOV analysis is 4 percent points for the complete sample based on an online survey conducted from May 22-25 in 1,109 adults in the United States.
